4//SEC Filing
Moran Michael Shawn 4
Accession 0001209191-22-002886
CIK 0000827871other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:42 PM ET
Size
4.8 KB
Accession
0001209191-22-002886
Insider Transaction Report
Form 4
Moran Michael Shawn
EVP, Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2022-01-07$50.63/sh−90$4,557→ 22,667 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy withholding tax obligations.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001886788
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:42 PM ET
- Size
- 4.8 KB